Interleukin-23 in early disease development in rheumatoid arthritis.
Identifieur interne : 000074 ( PubMed/Corpus ); précédent : 000073; suivant : 000075Interleukin-23 in early disease development in rheumatoid arthritis.
Auteurs : T. Andersen ; M. Hvid ; C. Johansen ; K. Stengaard-Pedersen ; M L Hetland ; K. H Rslev-Petersen ; P. Junker ; M. Stergaard ; B. DeleuranSource :
- Scandinavian journal of rheumatology ; 2015.
Abstract
To investigate the levels of interleukin (IL)-23 in patients with early rheumatoid arthritis (eRA) and the effect of anti-tumour necrosis factor (anti-TNF)-α treatment on IL-23 levels.
DOI: 10.3109/03009742.2015.1033007
PubMed: 26087654
Links to Exploration step
pubmed:26087654Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interleukin-23 in early disease development in rheumatoid arthritis.</title>
<author><name sortKey="Andersen, T" sort="Andersen, T" uniqKey="Andersen T" first="T" last="Andersen">T. Andersen</name>
</author>
<author><name sortKey="Hvid, M" sort="Hvid, M" uniqKey="Hvid M" first="M" last="Hvid">M. Hvid</name>
</author>
<author><name sortKey="Johansen, C" sort="Johansen, C" uniqKey="Johansen C" first="C" last="Johansen">C. Johansen</name>
</author>
<author><name sortKey="Stengaard Pedersen, K" sort="Stengaard Pedersen, K" uniqKey="Stengaard Pedersen K" first="K" last="Stengaard-Pedersen">K. Stengaard-Pedersen</name>
</author>
<author><name sortKey="Hetland, M L" sort="Hetland, M L" uniqKey="Hetland M" first="M L" last="Hetland">M L Hetland</name>
</author>
<author><name sortKey="H Rslev Petersen, K" sort="H Rslev Petersen, K" uniqKey="H Rslev Petersen K" first="K" last="H Rslev-Petersen">K. H Rslev-Petersen</name>
</author>
<author><name sortKey="Junker, P" sort="Junker, P" uniqKey="Junker P" first="P" last="Junker">P. Junker</name>
</author>
<author><name sortKey=" Stergaard, M" sort=" Stergaard, M" uniqKey=" Stergaard M" first="M" last=" Stergaard">M. Stergaard</name>
</author>
<author><name sortKey="Deleuran, B" sort="Deleuran, B" uniqKey="Deleuran B" first="B" last="Deleuran">B. Deleuran</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="doi">10.3109/03009742.2015.1033007</idno>
<idno type="RBID">pubmed:26087654</idno>
<idno type="pmid">26087654</idno>
<idno type="wicri:Area/PubMed/Corpus">000074</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Interleukin-23 in early disease development in rheumatoid arthritis.</title>
<author><name sortKey="Andersen, T" sort="Andersen, T" uniqKey="Andersen T" first="T" last="Andersen">T. Andersen</name>
</author>
<author><name sortKey="Hvid, M" sort="Hvid, M" uniqKey="Hvid M" first="M" last="Hvid">M. Hvid</name>
</author>
<author><name sortKey="Johansen, C" sort="Johansen, C" uniqKey="Johansen C" first="C" last="Johansen">C. Johansen</name>
</author>
<author><name sortKey="Stengaard Pedersen, K" sort="Stengaard Pedersen, K" uniqKey="Stengaard Pedersen K" first="K" last="Stengaard-Pedersen">K. Stengaard-Pedersen</name>
</author>
<author><name sortKey="Hetland, M L" sort="Hetland, M L" uniqKey="Hetland M" first="M L" last="Hetland">M L Hetland</name>
</author>
<author><name sortKey="H Rslev Petersen, K" sort="H Rslev Petersen, K" uniqKey="H Rslev Petersen K" first="K" last="H Rslev-Petersen">K. H Rslev-Petersen</name>
</author>
<author><name sortKey="Junker, P" sort="Junker, P" uniqKey="Junker P" first="P" last="Junker">P. Junker</name>
</author>
<author><name sortKey=" Stergaard, M" sort=" Stergaard, M" uniqKey=" Stergaard M" first="M" last=" Stergaard">M. Stergaard</name>
</author>
<author><name sortKey="Deleuran, B" sort="Deleuran, B" uniqKey="Deleuran B" first="B" last="Deleuran">B. Deleuran</name>
</author>
</analytic>
<series><title level="j">Scandinavian journal of rheumatology</title>
<idno type="e-ISSN">1502-7732</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To investigate the levels of interleukin (IL)-23 in patients with early rheumatoid arthritis (eRA) and the effect of anti-tumour necrosis factor (anti-TNF)-α treatment on IL-23 levels.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="In-Process"><PMID Version="1">26087654</PMID>
<DateCreated><Year>2016</Year>
<Month>02</Month>
<Day>18</Day>
</DateCreated>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1502-7732</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>44</Volume>
<Issue>6</Issue>
<PubDate><Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>Scandinavian journal of rheumatology</Title>
<ISOAbbreviation>Scand. J. Rheumatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Interleukin-23 in early disease development in rheumatoid arthritis.</ArticleTitle>
<Pagination><MedlinePgn>438-42</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate the levels of interleukin (IL)-23 in patients with early rheumatoid arthritis (eRA) and the effect of anti-tumour necrosis factor (anti-TNF)-α treatment on IL-23 levels.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">Treatment-naïve eRA patients from the OPERA cohort were included (n = 151). Patients were randomized to methotrexate (MTX) plus adalimumab (ADA; n = 75) or MTX plus placebo-ADA (PLA; n = 76). Plasma samples were obtained at baseline and at months 3, 6, and 12 together with values for C-reactive protein (CRP), the 28-joint Disease Activity Score based on CRP (DAS28CRP), scores on the Clinical Disease Activity Index (CDAI) and the Simplified Disease Activity Index (SDAI), visual analogue scale (VAS) for pain/fatigue/physician global and total Sharp/van der Heijde score (TSS). IL-23 was measured at each time point.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">IL-23 levels decreased significantly in the ADA group from 20.6 pg/mL (IQR 13.1-32.7 pg/mL) at baseline to 18 pg/mL (IQR 7.2-25.0 pg/mL) at 12 months (p < 0.01). No significant decrease in IL-23 level was observed in the PLA group. No associations between baseline IL-23 levels and measures of disease activity (DAS28CRP, CRP, CDAI, or SDAI) at 12 or 24 months were present in the treatment groups. Baseline IL-23 correlated inversely with changes in TSS and symptom duration before diagnosis.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data show increased baseline levels and a significant decrease in IL-23 levels in eRA patients treated with anti-TNF-α. The inverse correlation with duration of symptoms before diagnosis supports the importance of IL-23 in the preclinical disease development of RA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersen</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hvid</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Johansen</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Stengaard-Pedersen</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hetland</LastName>
<ForeName>M L</ForeName>
<Initials>ML</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hørslev-Petersen</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Junker</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Østergaard</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Deleuran</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Scand J Rheumatol</MedlineTA>
<NlmUniqueID>0321213</NlmUniqueID>
<ISSNLinking>0300-9742</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2015.1033007</ArticleId>
<ArticleId IdType="pubmed">26087654</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000074 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000074 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Musique |area= OperaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:26087654 |texte= Interleukin-23 in early disease development in rheumatoid arthritis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26087654" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a OperaV1
This area was generated with Dilib version V0.6.21. |